Literature DB >> 1299831

Timing of the window of uterine sensitivity to decidual stimuli in mice.

C A Finn1, M D Pope, S R Milligan.   

Abstract

The refractory period that follows the period of sensitivity to a decidual stimulus in ovariectomized hormone treated mice was investigated. Medroxyprogesterone acetate provided constant progestin concentrations and silastic implants containing oestradiol maintained constant nidatory oestrogen concentrations. The nidatory stimulus was provided by crushing the uterus with a haemostat or by the intrauterine instillation of arachis oil. The decidual response was assessed by measuring changes in uterine weight or by examining the stroma for the presence of alkaline phosphatase. Sensitivity to the oil was first observed approximately 14 h after the insertion of the oestradiol implant but this sensitivity had waned by 32 h and was absent at 40 h. Crushing the uterus initiated a decidual response in mice treated with progestin alone but if the oestradiol implant was inserted then the uterus was responsive to crushing 24 h after insertion but not at 45 h. The traumatic decidual cell reaction (crushing), although not requiring nidatory oestradiol for its successful initiation, was nevertheless subject to the refractoriness that followed oestradiol sensitivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1299831     DOI: 10.1071/rd9920565

Source DB:  PubMed          Journal:  Reprod Fertil Dev        ISSN: 1031-3613            Impact factor:   2.311


  2 in total

1.  Coordinate regulation of lymphocyte-endothelial interactions by pregnancy-associated hormones.

Authors:  Sirirak Chantakru; Wan-Chao Wang; Marianne van den Heuvel; Siamak Bashar; Amanda Simpson; Qing Chen; B Anne Croy; Sharon S Evans
Journal:  J Immunol       Date:  2003-10-15       Impact factor: 5.422

2.  Interferon gamma contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy.

Authors:  A A Ashkar; J P Di Santo; B A Croy
Journal:  J Exp Med       Date:  2000-07-17       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.